ArticleData in brief2025
Sub-network transcriptome dataset for diseases associated with exposure to bisphenol F and bisphenol S in human SH-SY5Y neuroblastoma cells.
Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bisphenol A replacement chemicals can result in toxicity to neuronal cells, however, the underlying mechanisms are not well characterized. Transcriptome analysis was conducted in the neuronal SH-SY5Y human cell line following exposure of cells to either bisphenol F (BPF) or bisphenol S (BPS) at a concentration of 0.1 nM. Transcriptome data were used to predict which diseases were associated with bisphenol exposure using sub-network enrichment analysis. There were 305 subnetworks perturbed by BPF and 279 subnetworks perturbed by BPS. Top gene sets altered by BPF included urticaria, gastric lesion, attention deficit disorder, familial Mediterranean fever, malocclusion, and lupus erythematosus while for BPS, top gene sets included chronic urticaria, polymyositis, genital herpes, and hypergammaglobulinemia. There were 164 common diseases identified between BPF and BPS datasets. These included protein regulators of androgen deficiency, cerebral toxoplasmosis, metabolic alkalosis, panic attack, T-helper lymphocyte infiltration and vitiligo. Data can be re-used in regulatory toxicology to characterize biomarkers of exposure and elucidate common molecular responses to bisphenol replacements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.